Metabolomic Markers of Fatigue in Inflammatory Bowel Disease

NCT04191707 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2019-12-10

No results posted yet for this study

Summary

Fatigue is a common symptom and a leading concern in patients with inflammatory bowel disease (IBD) and often persists despite clinical and endoscopic remission.

This study evaluates the metabolomic profile of fatigued patients with IBD.

Conditions

Sponsors & Collaborators

  • Corporacion Parc Tauli

    lead OTHER

Principal Investigators

  • Diana Horta · Parc Tauli Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-01
Primary Completion
2019-12-01
Completion
2019-12-01

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04191707 on ClinicalTrials.gov